The US Food and Drug Administration (FDA) has asked the maker of sodium polystyrene sulfonate (Kayexalate), Concordia Pharmaceuticals, to conduct studies of the drug's potential to interact with other ...
The Food and Drug Administration (FDA) announced that it will require the manufacturer of Kayexalate (sodium polystyrene sulfonate; Concordia Pharmaceuticals) to conduct studies on drug-drug ...
We have presented a case of NEC in a preterm infant affected by severe hyperkalemia and treated with SPS not suspended in sorbitol. SPS is a cation-exchange resin, which may be administered either ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results